(1)
Lima Cavalcanti, I. D.; Silveira Cabral, A. G.; dos Santos, R. J. Adverse Reactions for the Use of the Monoclonal Trastuzumab Antibody in the Treatment of Patients With HER2 Positive Breast Cancer. Ars Pharm 2017, 58, 171-174.